Clinical value of CT-guided 125I brachytherapy for retroperitoneal metastatic lymph node from PHC

National Medical Journal of China

Volumn 93, Issue 27, 2013, Pages 2155-2157

  Gao, Fei ^a   Gu, Yang Kui ^a   Huang, Jin Hua ^a   Zhang, Fu Jun ^a   Wu, Pei Hong ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

Liver neoplasms; Lymphatic metastasis; Retroperitoneal neoplasms

Indexed keywords

RADIOACTIVE SEED;

ARTICLE; BLEEDING; BRACHYTHERAPY; CANCER RECURRENCE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; FOLLOW UP; HUMAN; LIVER CELL CARCINOMA; LYMPH NODE METASTASIS; PARAAORTIC LYMPH NODE; PRIMARY HEPATIC CARCINOMA; QUALITY CONTROL; RADIATION INJURY; TREATMENT PLANNING;

BRACHYTHERAPY; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; LIVER NEOPLASMS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; RETROPERITONEAL SPACE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84881003586     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2013.27.017     Document Type: Article

References (15)

1. Zeng Z C, Tang Z Y, Fan J, et al. Consideration of role of radiotherapy for lymph node metastases in patients with HCC: retrospective analysis for prognostic factors from 125 patients. Int J Radiat Oncol Biol Phys, 2005, 63: 1067-1076.
2. Une Y, Misawa K, Shimamura T, et al. Treatment of lymph node recurrence in patients with hepatocellular carcinoma. Surg Today, 1994, 24: 606-609.
3. Bagshaw M A, Cox R S, Ramback J E. Radiation therapy for localized prostate cancer. Justification by long-term follow-up. Urol Clin North Am, 1990, 17: 787-802.
4. 2004, 38: 906-909.
5. 2004, 38: 910-915.
6. Johnson M, Colonias A, Parda D, et al. Dosimetric and technical aspects of intraoperative 1-125 brachytherapy for stage I non-small cell lung cancer. Phys Med Biol, 2007, 52: 1237-1245.
7. Peretz T, Nori D, Hilaris B, et al. Treatment of primary unresectable carcinoma of the pancreas with 1-125 implantation. Int J Radiat Oncol Biol Phys, 1989, 17: 931-935.
8. 2006, 86: 223-227.
9. Ebara S, Katayama N, Tanimoto R, et al. Iodine-125 seed implantation (permanent brachytherapy) for clinically localized prostate cancer. Acta Med Okayama, 2008, 62: 9-13.
10. Zhang F J, Li C X, Zhang L, et al. Short- to mid-term evaluation of CT-guided 1251 brachytherapy on intra-hepatic recurrent tumors and/or extra-hepatic metastases after liver transplantation for hepatocellular carcinoma. Cancer Biol Ther, 2009, 8: 585-590.
11. Xiaohong S, Huikai L, Feng W, et al. Clinical significance of lymph node metastasis in patients undergoing partial hepatectomy for hepatocellular carcinoma. World J Surg, 2010, 34: 1028-1033.
12. Ercolani G, Grazi G L, Ravaioli M, et al. The role of lymphadenectomy for liver tumors: further considerations on the appropriateness of treatment strategy. Ann Surg, 2004, 239: 202-209.
13. Nath R, Anderson L L, Luxton G, et al. Dosimetry of interstitial brachytherapy sources: recommendations of the AAPM Radiation Therapy Committee Task Group No. 43. American Association of Physicists in Medicine. Med Phys, 1995, 22: 209-234.
14. Lee E K, Zaider M. Intraoperative dynamic dose optimization in permanent prostate implants. Int J Radiat Oncol Biol Phys, 2003, 56: 854-861.
15. 2008, 27: 1082-1087.